FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1972442948> ?p ?o ?g. }

• W1972442948 endingPage "603" @default.
• W1972442948 startingPage "596" @default.
• W1972442948 abstract "Due to their small size, the respirable drug particles tend to form agglomerates which prevent flowing and aerosolisation. A carrier is used to be mixed with drug in one hand to facilitate the powder flow during manufacturing, in other hand to help the fluidisation upon patient inhalation. Depending on drug concentration, drug agglomerates can be formed in the mixture. The aim of this work was to study the agglomeration behaviour of fluticasone propionate (FP) within interactive mixtures for inhalation. The agglomerate phenomenon of fluticasone propionate after mixing with different fractions of lactose without fine particles of lactose (smaller than 32 μm) was demonstrated by the optical microscopy observation. A technique measuring the FP size in the mixture was developed, based on laser diffraction method. The FP agglomerate sizes were found to be in a linear correlation with the pore size of the carrier powder bed (R(2)=0.9382). The latter depends on the particle size distribution of carrier. This founding can explain the role of carrier size in de-agglomeration of drug particles in the mixture. Furthermore, it gives more structural information of interactive mixture for inhalation that can be used in the investigation of aerosolisation mechanism of powder. According to the manufacturing history, different batches of FP show different agglomeration intensities which can be detected by Spraytec, a new laser diffraction method for measuring aerodynamic size. After mixing with a carrier, Lactohale LH200, the most cohesive batch of FP, generates a lower fine particle fraction. It can be explained by the fact that agglomerates of fluticasone propionate with very large size was detected in the mixtures. By using silica-gel beads as ball-milling agent during the mixing process, the FP agglomerate size decreases accordingly to the quantity of mixing aid. The homogeneity and the aerodynamic performance of the mixtures are improved. The mixing aid based on ball-milling effect could be used to ameliorate the quality of inhalation mixture of cohesive drug, such as fluticasone propionate. However, there is a threshold where an optimal amount of mixing aids should be used. Not only the drug des-aggregation reaches its peak but the increase in drug-carrier adhesion due to high energy input should balance the de-agglomeration capacity of mixing process. This approach provides a potential alternative in DPI formulation processing." @default.
• W1972442948 created "2016-06-24" @default.
• W1972442948 creator A5063291398 @default.
• W1972442948 creator A5072082220 @default.
• W1972442948 creator A5074619051 @default.
• W1972442948 date "2012-04-01" @default.
• W1972442948 modified "2023-09-28" @default.
• W1972442948 title "Agglomerate behaviour of fluticasone propionate within dry powder inhaler formulations" @default.
• W1972442948 cites W1970277407 @default.
• W1972442948 cites W1970501208 @default.
• W1972442948 cites W1976926719 @default.
• W1972442948 cites W1978489475 @default.
• W1972442948 cites W1985558994 @default.
• W1972442948 cites W2003665796 @default.
• W1972442948 cites W2005316212 @default.
• W1972442948 cites W2007216535 @default.
• W1972442948 cites W2011064588 @default.
• W1972442948 cites W2012658698 @default.
• W1972442948 cites W2015076467 @default.
• W1972442948 cites W2016232999 @default.
• W1972442948 cites W2018227496 @default.
• W1972442948 cites W2020128960 @default.
• W1972442948 cites W2025776529 @default.
• W1972442948 cites W2026878175 @default.
• W1972442948 cites W2030087135 @default.
• W1972442948 cites W2037593395 @default.
• W1972442948 cites W2040593024 @default.
• W1972442948 cites W2051060290 @default.
• W1972442948 cites W2051420333 @default.
• W1972442948 cites W2056858263 @default.
• W1972442948 cites W2057688309 @default.
• W1972442948 cites W2062398284 @default.
• W1972442948 cites W2075452481 @default.
• W1972442948 cites W2081441319 @default.
• W1972442948 cites W2081513817 @default.
• W1972442948 cites W2089540857 @default.
• W1972442948 cites W2093871026 @default.
• W1972442948 cites W2116457340 @default.
• W1972442948 cites W2133054447 @default.
• W1972442948 cites W4242974296 @default.
• W1972442948 cites W92762380 @default.
• W1972442948 doi "https://doi.org/10.1016/j.ejpb.2011.12.004" @default.
• W1972442948 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22198291" @default.
• W1972442948 hasPublicationYear "2012" @default.
• W1972442948 type Work @default.
• W1972442948 sameAs 1972442948 @default.
• W1972442948 citedByCount "25" @default.
• W1972442948 countsByYear W19724429482012 @default.
• W1972442948 countsByYear W19724429482013 @default.
• W1972442948 countsByYear W19724429482014 @default.
• W1972442948 countsByYear W19724429482015 @default.
• W1972442948 countsByYear W19724429482016 @default.
• W1972442948 countsByYear W19724429482017 @default.
• W1972442948 countsByYear W19724429482018 @default.
• W1972442948 countsByYear W19724429482020 @default.
• W1972442948 countsByYear W19724429482022 @default.
• W1972442948 crossrefType "journal-article" @default.
• W1972442948 hasAuthorship W1972442948A5063291398 @default.
• W1972442948 hasAuthorship W1972442948A5072082220 @default.
• W1972442948 hasAuthorship W1972442948A5074619051 @default.
• W1972442948 hasConcept C105702510 @default.
• W1972442948 hasConcept C120665830 @default.
• W1972442948 hasConcept C121332964 @default.
• W1972442948 hasConcept C126322002 @default.
• W1972442948 hasConcept C127413603 @default.
• W1972442948 hasConcept C129955480 @default.
• W1972442948 hasConcept C131850264 @default.
• W1972442948 hasConcept C159985019 @default.
• W1972442948 hasConcept C177562468 @default.
• W1972442948 hasConcept C178790620 @default.
• W1972442948 hasConcept C185592680 @default.
• W1972442948 hasConcept C187530423 @default.
• W1972442948 hasConcept C192562407 @default.
• W1972442948 hasConcept C2776042228 @default.
• W1972442948 hasConcept C2776954882 @default.
• W1972442948 hasConcept C2777419714 @default.
• W1972442948 hasConcept C2778724459 @default.
• W1972442948 hasConcept C2779028295 @default.
• W1972442948 hasConcept C2780261241 @default.
• W1972442948 hasConcept C42360764 @default.
• W1972442948 hasConcept C43617362 @default.
• W1972442948 hasConcept C60448018 @default.
• W1972442948 hasConcept C71924100 @default.
• W1972442948 hasConceptScore W1972442948C105702510 @default.
• W1972442948 hasConceptScore W1972442948C120665830 @default.
• W1972442948 hasConceptScore W1972442948C121332964 @default.
• W1972442948 hasConceptScore W1972442948C126322002 @default.
• W1972442948 hasConceptScore W1972442948C127413603 @default.
• W1972442948 hasConceptScore W1972442948C129955480 @default.
• W1972442948 hasConceptScore W1972442948C131850264 @default.
• W1972442948 hasConceptScore W1972442948C159985019 @default.
• W1972442948 hasConceptScore W1972442948C177562468 @default.
• W1972442948 hasConceptScore W1972442948C178790620 @default.
• W1972442948 hasConceptScore W1972442948C185592680 @default.
• W1972442948 hasConceptScore W1972442948C187530423 @default.
• W1972442948 hasConceptScore W1972442948C192562407 @default.
• W1972442948 hasConceptScore W1972442948C2776042228 @default.
• W1972442948 hasConceptScore W1972442948C2776954882 @default.

• next